Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Resource Type
Article
Authors
Albrecht, Lea Jessica ; Dimitriou, Florentia ; Grover, Piyush ; Hassel, Jessica C. ; Erdmann, Michael ; Forschner, Andrea ; Johnson, Douglas B. ; Váraljai, Renáta ; Lodde, Georg ; Placke, Jan Malte ; Krefting, Frederik ; Zaremba, Anne ; Ugurel, Selma ; Roesch, Alexander ; Schulz, Carsten ; Berking, Carola ; Pöttgen, Christoph ; Menzies, Alexander M. ; Long, Georgina V. ; Dummer, Reinhard ; Livingstone, Elisabeth ; Schadendorf, Dirk ; Zimmer, Lisa
Source
In European Journal of Cancer May 2024 202
Subject
MSC
Language
ISSN
0959-8049